Stories from United States

A portion of home insurance claims are resulting in zero payout for policyholders. This trend is impacting the financial outcomes for nearly half of all claims filed.

NVIDIA has announced its new AI technology called NemoClaw, signaling the start of a personal artificial intelligence era. Airbnb reported that 60% of its new code is now written by AI. The company stated that this technology marks the beginning of the era of personal AI.

Google has released a new artificial intelligence dictation application for iOS devices. Google is releasing 32 million male mosquitoes infected with Wolbachia bacteria in California and Florida over the next two years.

Apple is facing a shock lawsuit related to artificial intelligence. The lawsuit was mentioned in a technology news report.

Luminous Fidget Spinner Balls have been recalled due to the risk of serious injury or death from battery ingestion.

The National Weather Service issued a severe thunderstorm warning for the Omaha/Valley, Nebraska area. The warning is in effect until 10:45 PM CDT on May 30. Residents are advised to prepare for potential severe weather conditions. Louis, Missouri area on May 31 at 1:08 PM CDT.

A 25-year-old woman, Priscilla R. Mafalda, has been identified as the deceased victim in a fatal collision. A preliminary investigation suggests a bus struck the Chevrolet Suburban Mafalda was driving, forcing it off the road.

The San Antonio Spurs defeated the Oklahoma City Thunder in Game 7 of the Western Conference Finals, advancing to the NBA Finals. The NBA Finals matchup is set, with ticket prices for games in San Antonio and New York ranging from $2,021 to $4,201.

Radio broadcasts are discussing the current economic situation and its impact on oil sales. The role of oil prices in inflation is a key topic.

The FDA's vaccine advisors voted 8 to 0, with one abstention, in favor of a monovalent XFG vaccine aimed at the dominant strain. The vote occurred during a panel meeting. These vaccines are expected to offer enhanced protection against current and future variants. The vaccines are designed to target emerging variants.